Search Tag: Giuseppe Recchi
Affidea-group-appoints-new-chief-executive-officer
2018 25 Jan
The Board of the Affidea Group BV are pleased to announce the appointment of Mr. Giuseppe Recchi as the new Chief Executive Officer of the Group, effective immediately. Giuseppe Recchi joins Affidea from Telecom Italia, where, since September 2017 he is Deputy Chairman, having previously been Executive Chairman since April 2014. Prior to that he...Read more
How-artificial-intelligence-spells-real-change-for-patients-1
2018 07 Nov
“At Affidea, the scale of our operation gives us unique capabilities in AI, including rich data sets which we can use to drive forward innovations in patient care both internally and with our partners. We want to help create a future where healthcare professionals can devote their time to doing what they do best – delivering the best possible care...Read more
Digitizing-healthcare
2019 21 Jan
Affidea launches new digital tools in its network to improve patient experience and boost operations workflow. Affidea, the leading pan-European provider of advanced diagnostic imaging, outpatient and cancer care services, has announced the launch of two new applications to drive forward the digitisation of its operations and increase productivity...Read more
World-cancer-day-2019-affidea-expands-its-european-footprint-in-cancer-care
2019 04 Feb
Affidea, the leading European provider of advanced diagnostic imaging, outpatient and cancer care services, announces, on World Cancer Day, its plans to expand its cancer care network, developing its European footprint to increase access to high quality oncological treatment and diagnostic imaging services. Across Europe, the incidence of cancer...Read more
Affidea-announces-first-ai-partnership-with-icometrix-to-improve-care-for-ms-patients
2019 01 Mar
Affidea and icometrix have today announced a strategic partnership to streamline and improve the care of patients with neurological disorders in Europe, with the rollout of a new AI tool for patients with multiple sclerosis (MS). As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration...Read more
Know-more-treat-better
2019 22 May
Affidea applies ground-breaking AI technology on Brain MRI examinations for people with Multiple Sclerosis Affidea has entered into a partnership with icometrix, a data science company that develops Artificial Intelligence (AI) solutions for healthcare, to standardise and improve the care of patients with neurological disorders. The official...Read more
Affidea-announces-mpg-acquisition-in-lithuania
2019 02 Jul
Affidea Continues its Expansions Plans with a New Acquisition that Doubles its Presences in Lituania Company Reaches 256 Centres at European Level Affidea, the leading European provider of diagnostic imaging, outpatient and cancer care services announces that it has successfully completed the acquisition of UAB Medicinos Paslaugų Grupė (MPG)...Read more
Affidea-partners-with-screenpoint-medical-to-increase-diagnostic-accuracy-of-screening-mammography
2019 11 Jul
Affidea and ScreenPoint Medical announced a strategic partnership to streamline and improve the clinical performance of screening mammography and drive the earlier detection of breast cancer. The partnership will leverage Affidea’s growing footprint in the European breast imaging marketplace and will provide a unique opportunity for ScreenPoint...Read more
Affidea-continues-its-expansion-plans-with-a-new-acquisition-in-italy
2019 29 Jul
Affidea Group, the leading European provider of diagnostic imaging, outpatient and cancer care services announces today that it has completed the acquisition of NSL Health Centers in Rome, Italy. This is Affidea’s third acquisition in the last three months proving the company’s ambition to strengthen its leading position in Europe with the network...Read more
Better-insight-better-peace-of-mind
2019 26 Aug
Enhanced diagnostic accuracy of screening mammography with the use of Artificial Intelligence Breast cancer is the most frequent cancer among women, with an estimated incidence of 560,000 cases in 2018, in Europe. 1 The World Health Organisation (WHO) estimated that 627,000 women worldwide, 2 out of which 150.0002 only in Europe, died from...Read more
Beyond-imaging-towards-a-care-pathway-approach-powered-by-ai
2019 13 Nov
The healthcare industry is under transformation. An ageing population and the rise of noncommunicable diseases are driving an industry shift away from curing disease in the short term toward preventing and managing disease and promoting overall well-being in the long term. Across Europe, we see the same issues – underfunded and understaffed national...Read more
Message-of-affidea-ceo-giuseppe-recchi-on-international-day-of-radiology
2019 09 Nov
We are celebrating today the International Day of Radiology (IDOR), which marks a remarkable 124 years since Wilhelm Röntgen discovered x-rays. As a leading European provider of diagnostic imaging services, we know that radiology is at the core of every clinical decision making. This year's IDOR’s main theme is sports imaging as radiologists...Read more
Affidea-partners-with-aidence-in-lung-cancer-diagnosis-and-screening-with-the-use-of-ai
2019 04 Dec
Affidea and Aidence announce a strategic partnership to streamline and improve the clinical performance of lung diagnosis and screening to drive the earlier detection and treatment in the case of lung cancer. As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical...Read more
Affidea-and-ge-healthcare-sign-a-100-million-technology-partnership
2019 02 Dec
Affidea and GE Healthcare sign a $100 million technology partnership agreement for innovative imaging fleet, digital workflow solutions and contrast media GE Healthcare and Affidea , the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies...Read more
Affidea-group-expands-into-uk-through-acquisition-of-fortius-clinic
2021 02 Mar
Affidea Group, the leading European provider of diagnostic imaging, outpatient and cancer care services has today announced the acquisition of Fortius Clinic, the UK’s single largest orthopedic group with an international reputation in orthopaedics and MSK. This acquisition represents a strategic milestone for Affidea and fits perfectly with the company’s...Read more
Affidea-on-an-ambitious-expansion-path
2021 01 Jul
Affidea , on an ambitious expansion path - The European medical provider successfully completes the strategic acquisition of Gruppo CDC and becomes the largest outpatient medical provider in Italy. Affidea reaches 308 centers at European level, seeing almost 10 million patients every year The new acquisition sets Affidea as...Read more
Governance-and-management-changes-at-affidea
2022 01 Sep
Following its July acquisition of a majority stake in Affidea, the largest European provider of advanced diagnostics, outpatient and cancer care services, GBL is initiating changes in the company’s governance, including the composition of a new Supervisory Board. Guy Blomfield, former CEO of Alliance Medical Group, has been appointed Chairman...Read more